CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 4 Option exercise CEO acquired 328,125 shares (option exercise)
- 8-K Event Executive or director change
- SC 13G/A Stake Amended Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 8-K Event Other events
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy Director bought 3,975 shares at $0.54 ($2,147)
- 4 Open-market buy Director bought 11,000 shares at an average $0.49 ($5,380)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy Director bought 4,000 shares at $0.53 ($2,120)
- 8-K Event Executive or director change · Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market buy Director bought 400,000 shares at $0.23 ($92,000)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale 10% owner sold 400,000 shares at $0.23 ($92,000)
- 10-Q Report Quarterly Report
Page 52 of 77 · 1,525 filings